Why Building a Defensible Patent Portfolio Is Critical for Biotech

Directors Deborah Sterling and Jeremiah Frueauf presented the “Why Building a Defensible Patent Portfolio Is Critical for Biotech” seminar hosted by Biocant Park. The seminar discussed the main strategies for identifying what to protect, when and how to protect it, and the importance of continually reviewing and realigning your intellectual property (IP) protection strategy.

Key topics covered:

1. Strategic IP Planning: developing an IP plan that aligns with your business goals and reduces legal uncertainties
2. Licensing and Collaboration: leveraging your IP for revenue generation and partnerships while avoiding common pitfalls
3. Competitor Monitoring: how to proactively address potential threats in the competitive landscape.
4. Freedom to Operate (FTO): essential practices to ensure that your innovation can be practiced without legal barriers